Capsid stabilization reprograms the nuclear fate of the HIV genome
Science Advances · 2026-08-07 · 12 (32)
DOI: 10.1126/sciadv.aef9469 ↗At a glance
Journal article in Science Advances, published on 2026-08-07. Written by Thierry Mourer and 13 co-authors. Institution: Virology Department, Institut Pasteur, Université Paris Cité, Paris, France. Major MEDLINE topics: HIV-1, Capsid, Genome, Viral, Cell Nucleus. 86 references. The full text is freely available in PubMed Central. Funded by: Engineering and Physical Sciences Research Council, Agence Nationale de la Recherche, ANR/PRCI.
Abstract (original language)
Capsid stabilization, induced by low-nanomolar concentrations of Lenacapavir (LEN)—a first-in-class capsid inhibitor—impedes HIV-1 replication in macrophages without disrupting reverse transcription or nuclear import. In LEN-treated cells, ultrastructural analyses reveal preserved conical capsids persisting within nuclear CPSF6-enriched puncta—HIV-1–induced membraneless organelles (HIV-1–MLOs)—which remain spatially segregated from canonical integration hubs near nuclear speckles (NSs). Rather than fusing with NSs, HIV-1–MLOs are rerouted to chromatin-associated promyelocytic leukemia nuclear bodies (PML-NBs), where molecular exchange occurs without condensate fusion. This nuclear redirection correlates with the sequestration of the viral genome within stabilized capsids, reducing the pool of viral DNA available for integration and redirecting the few accessible genomes to atypical integration sites near PML-NBs. These findings uncover a previously unrecognized mechanism of LEN action, whereby capsid stabilization reprograms the nuclear fate of the HIV-1 genome in macrophages, limiting integration and redirecting viral DNA toward more repressive nuclear environments, likely shaping the transcriptional potential of newly integrated viral DNA.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Virology Department, Institut Pasteur, Université Paris Cité, Paris, France.
- Image Analysis Hub (IAH), Institut Pasteur, Université Paris Cité, Paris, France.
- Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.
- NanoImaging Core Facility (NCF), Institut Pasteur, Université Paris Cité, Paris, France.
- Genethon, Evry, France.
- Université Paris-Saclay, University of Evry, Inserm, Généthon, Integrare Research Unit UMR_S951, Evry-Courcouronnes, France.
ORCID profiles: Thierry Mourer, Mohamad Harastani, Jose Ignacio Perez-Lopez, Stephane Tachon, Guillaume Corre, Maria Julia Maristany, Jean-Yves Tinevez, Anastasia Gazi, Valentina Poletti, Rosana Collepardo-Guevara, Anna Sartori-Rupp, Francesca Di Nunzio
Funding
- Engineering and Physical Sciences Research Council
- Agence Nationale de la Recherche
- ANR/PRCI
- Institut Carnot/PTR
- Agence Nationale de Recherches sur le Sida et les Hepatites Virales
- EPSRC
- UKRI-EPSRC
- ERC
Cite
APA
Mourer, T., Harastani, M., Cuche, C., Perez-Lopez, J. I., Tornambe, S., Tachon, S., Corre, G., Maristany, M. J., Tinevez, J. Y., Gazi, A., Poletti, V., Collepardo-Guevara, R., Sartori-Rupp, A., & Di Nunzio, F. (2026). Capsid stabilization reprograms the nuclear fate of the HIV genome. Science Advances, 12(32). https://doi.org/10.1126/sciadv.aef9469
Vancouver
Mourer T, Harastani M, Cuche C, Perez-Lopez JI, Tornambe S, Tachon S, et al. Capsid stabilization reprograms the nuclear fate of the HIV genome. Science Advances. 2026;12(32). doi:10.1126/sciadv.aef9469
BibTeX
@article{Mourer2026,
author = {Mourer, Thierry and Harastani, Mohamad and Cuche, Celine and Perez-Lopez, Jose Ignacio and Tornambe, Salvatore and Tachon, Stephane and Corre, Guillaume and Maristany, Maria Julia and Tinevez, Jean-Yves and Gazi, Anastasia and Poletti, Valentina and Collepardo-Guevara, Rosana and Sartori-Rupp, Anna and Di Nunzio, Francesca},
title = {Capsid stabilization reprograms the nuclear fate of the HIV genome},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {32},
doi = {10.1126/sciadv.aef9469}
}
EUVIMED